|
| Status |
Public on Mar 10, 2022 |
| Title |
Epigenetic activation of plasmacytoid DC drives IFNAR-dependent therapeutic differentiation of AML |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
35311997 |
| |
| Submission date |
Mar 07, 2022 |
| Last update date |
Jun 09, 2022 |
| Contact name |
Izabela Todorovski |
| E-mail(s) |
izabela.todorovski@petermac.org
|
| Organization name |
Peter MacCallum Centre
|
| Department |
Cancer Research Division
|
| Lab |
Gene Regulation
|
| Street address |
305 Grattan Street
|
| City |
Melbourne |
| State/province |
VIC |
| ZIP/Postal code |
3000 |
| Country |
Australia |
| |
|
| Platforms (3) |
| GPL13112 |
Illumina HiSeq 2000 (Mus musculus) |
| GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (35)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE198113 |
Epigenetic activation of plasmacytoid DC drives IFNAR-dependent therapeutic differentiation of AML [RNAseq WT tumor cells] |
| GSE198114 |
Epigenetic activation of plasmacytoid DC drives IFNAR-dependent therapeutic differentiation of AML [RNAseq IFNAR KO tumor cells] |
| GSE198115 |
Epigenetic activation of plasmacytoid DC drives IFNAR-dependent therapeutic differentiation of AML [RNAseq DC] |
| GSE198116 |
Epigenetic activation of plasmacytoid DC drives IFNAR-dependent therapeutic differentiation of AML [ChIPseq DC] |
| GSE198117 |
Epigenetic activation of plasmacytoid DC drives IFNAR-dependent therapeutic differentiation of AML [ATACseq DC] |
| GSE198118 |
Epigenetic activation of plasmacytoid DC drives IFNAR-dependent therapeutic differentiation of AML [scRNAseq DC] |
|
| Relations |
| BioProject |
PRJNA813640 |
Less...
More...